Amoy Diagnostics Co., Ltd.

Symbol: 300685.SZ

SHZ

20.6

CNY

Market price today

  • 34.8241

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 8.13B

    MRK Cap

  • 0.01%

    DIV Yield

Amoy Diagnostics Co., Ltd. (300685-SZ) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.89%

Operating Profit Margin

0.28%

Net Profit Margin

0.25%

Return on Assets

0.13%

Return on Equity

0.16%

Return on Capital Employed

0.15%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO:Mr. Jiemin Luo
Full-time employees:1101
City:Xiamen
Address:39 Dingshan Road
IPO:2017-08-03
CIK:

Amoy Diagnostics Co., Ltd., a diagnostic company, focuses on molecular diagnostics for oncology precision medicine in China and internationally. The company offers NGS, real-time PCR, FISH, and extraction assays. Amoy Diagnostics Co., Ltd. was founded in 2008 and is based in Xiamen, China.

General Outlook

When we look at how much money they make before expenses, they keep 0.889% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.283%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.246%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.132% return, is a testament to Amoy Diagnostics Co., Ltd.'s adeptness in optimizing resource deployment. Amoy Diagnostics Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.160%. Furthermore, the proficiency of Amoy Diagnostics Co., Ltd. in capital utilization is underscored by a remarkable 0.152% return on capital employed.

Stock Prices

Amoy Diagnostics Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $22.89, while its low point bottomed out at $22.01. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Amoy Diagnostics Co., Ltd.'s stock market.

Profitability Ratios

300685.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 27.67% underscores its earnings before tax deductions. The effective tax rate stands at 11.25%, revealing its tax efficiency. The net income per EBT, 88.75%, and the EBT per EBIT, 97.84%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 28.28%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin27.67%
Effective Tax Rate11.25%
Net Income per EBT88.75%
EBT per EBIT97.84%
EBIT per Revenue28.28%

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.53, and free cash flow per share, 0.44, depict cash generation on a per-share basis. A payout ratio of 0.22 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.21, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.53
Free Cash Flow per Share0.44
Payout Ratio0.22
Operating Cash Flow Sales Ratio0.21
Free Cash Flow to Operating Cash Flow Ratio0.83
Capital Expenditure Coverage Ratio5.92
Dividend Paid and Capex Coverage Ratio2.33

Debt and Leverage Ratios

An interest coverage of 348.54 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Interest Coverage348.54
Company Equity Multiplier1.14

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 23.91%, indicates top-line expansion, while the gross profit growth, 50.29%, reveals profitability trends. EBIT growth, 2.60%, and operating income growth, 2.60%, offer insights into operational profitability progression. The net income growth, -2.84%, showcases bottom-line expansion, and the EPS growth, -4.48%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth23.91%
Gross Profit Growth50.29%
EBIT Growth2.60%
Operating Income Growth2.60%
Net Income Growth-2.84%
EPS Growth-4.48%
EPS Diluted Growth-100.00%
Weighted Average Shares Growth-100.00%
Weighted Average Shares Diluted Growth-100.00%
Dividends per Share Growth-100.00%
Operating Cash Flow Growth-100.00%
Free Cash Flow Growth-100.00%
5-Year Revenue Growth per Share-100.00%
3-Year Revenue Growth per Share-100.00%
5-Year Operating CF Growth per Share-100.00%
3-Year Operating CF Growth per Share-100.00%
5-Year Net Income Growth per Share-100.00%
3-Year Net Income Growth per Share-100.00%
5-Year Shareholders Equity Growth per Share-100.00%
3-Year Shareholders Equity Growth per Share-100.00%
5-Year Dividend per Share Growth per Share-100.00%
3-Year Dividend per Share Growth per Share-100.00%
Receivables Growth-100.00%
Inventory Growth-100.00%
Asset Growth17.91%
Book Value per Share Growth-100.00%
Debt Growth-100.00%
R&D Expense Growth-100.00%
SGA Expenses Growth-100.00%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 5.25, and the price to book ratio, 5.25, reflect the market's valuation relative to the company's book value. The price to sales ratio, 8.35, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 48.49, and price to operating cash flows, 41.29, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio5.25
Price to Book Ratio5.25
Price to Sales Ratio8.35
Price Cash Flow Ratio41.29
Enterprise Value Multiple30.86
Price Fair Value5.25
Price to Operating Cash Flow Ratio41.29
Price to Free Cash Flows Ratio48.49
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Amoy Diagnostics Co., Ltd. (300685.SZ) on the SHZ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 34.824 in 2024.

What is the ticker symbol of Amoy Diagnostics Co., Ltd. stock?

The ticker symbol of Amoy Diagnostics Co., Ltd. stock is 300685.SZ.

What is company IPO date?

IPO date of Amoy Diagnostics Co., Ltd. is 2017-08-03.

What is company current share price?

Current share price is 20.600 CNY.

What is stock market cap today?

The market cap of stock today is 8129960444.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 1101.